Poemlarp Mekraksakit is a Nephrology physician. OpenAlex indexes 77 publications with 641 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
305 Memorial Medical Pkwy Ste 507
Daytona Beach, FL 321175170
Telephone
386-672-8595Provider last certified this registry record 11 Mar 2026.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ardelyx, Inc.Program year20252 payments
- Bayer Healthcare Pharmaceuticals Inc.Program year20251 payment
- Renalytix AI, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.5%Calcium channel blocker20.8%Amlodipine Besylate100%Part D≥12 patientsAngiotensin receptor blocker (ARB)20.1%Losartan Potassium63%Irbesartan37%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
27.5%SGLT2 inhibitor14.1%Farxiga100%Part D<11 patientsH2 blocker13.4%Famotidine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Genotype–phenotype correlations and clinical outcomes of genetic <i>TRPC6</i> podocytopathies
Nephrology Dialysis Transplantation
2025 - Monoclonal gammopathy associates with kidney failure in ANCA-associated vasculitis
Nephrology Dialysis Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”